This supports the notion that TR-AM glycolysis evolved to support cellular function under hypoxic conditions and demonstrates that HIF-1α induction promotes TR-AM survival during ARDS, a condition marked by TR-AM loss and mitochondrial dysfunction. This evidence concerns the gene HIF1A and acute respiratory distress syndrome.